StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.68−0.02 (-1.18%)

Close on Nov 17, 2026Market cap $1.13MP/E –Yield –

Artelo Biosciences cash

Cash and short-term investments held at the end of each period.

Artelo Biosciences's cash was $4.20M at Jun 30, 2026. For fiscal 2025 it was $600.00K, down 74.3% from the year before. Over ten years it grew 44.9% a year on average. The highest annual figure on record is $10.43M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$600.00K-74.3%
FY2024Dec 31, 2024$2.34M-77.6%
FY2023Dec 31, 2023$10.43M+3.6%
FY2021Aug 31, 2021$10.07M+369.9%
FY2020Aug 31, 2020$2.14M-51.6%
FY2019Aug 31, 2019$4.42M+1211.1%
FY2018Aug 31, 2018$337.42K-41.1%
FY2017Aug 31, 2017$572.78K+15854.7%
FY2016Aug 31, 2016$3.59K-78.9%
FY2015Aug 31, 2015$17.03K+15.6%
FY2014Aug 31, 2014$14.73K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$4.20M+103.2%
Q1 FY2026CQ1 2026Mar 31, 2026$4.20M+462.7%
Q4 FY2025CQ4 2025Dec 31, 2025$600.00K-74.3%
Q3 FY2025CQ3 2025Sep 30, 2025$1.72M-64.6%
Q2 FY2025CQ2 2025Jun 30, 2025$2.07M-63.1%
Q1 FY2025CQ1 2025Mar 31, 2025$746.00K-90.2%
Q4 FY2024CQ4 2024Dec 31, 2024$2.34M-77.6%
Q3 FY2024CQ3 2024Sep 30, 2024$4.86M-62.2%
Q2 FY2024CQ2 2024Jun 30, 2024$5.60M-60.0%
Q1 FY2024CQ1 2024Mar 31, 2024$7.61M-50.9%
Q4 FY2023CQ4 2023Dec 31, 2023$10.43M+3.6%
Q3 FY2023CQ3 2023Sep 30, 2023$12.86M+28.0%
Q2 FY2023CQ2 2023Jun 30, 2023$13.99M+24.7%
Q1 FY2023CQ1 2023Mar 31, 2023$15.48M+109.5%
Q4 FY2021CQ3 2021Aug 31, 2021$10.07M+369.9%
Q3 FY2021CQ2 2021May 31, 2021$10.05M+685.8%
Q2 FY2021CQ1 2021Feb 28, 2021$11.22M+465.9%
Q1 FY2021CQ4 2020Nov 30, 2020$7.39M+119.0%
Q4 FY2020CQ3 2020Aug 31, 2020$2.14M-51.6%
Q3 FY2020CQ2 2020May 31, 2020$1.28M+346.6%
Q2 FY2020CQ1 2020Feb 29, 2020$1.98M+333.5%
Q1 FY2020CQ4 2019Nov 30, 2019$3.37M+2832.6%
Q4 FY2019CQ3 2019Aug 31, 2019$4.42M+1211.1%
Q3 FY2019CQ2 2019May 31, 2019$286.44K-12.1%
Q2 FY2019CQ1 2019Feb 28, 2019$457.33K-12.9%
Q1 FY2019CQ4 2018Nov 30, 2018$115.07K-72.1%
Q4 FY2018CQ3 2018Aug 31, 2018$337.42K-41.1%
Q3 FY2018CQ2 2018May 31, 2018$326.02K+43.1%
Q2 FY2018CQ1 2018Feb 28, 2018$525.11K+4718.8%
Q1 FY2018CQ4 2017Nov 30, 2017$412.44K+11388.6%
Q4 FY2017CQ3 2017Aug 31, 2017$572.78K+15854.7%
Q3 FY2017CQ2 2017May 31, 2017$227.84K+6246.5%
Q2 FY2017CQ1 2017Feb 28, 2017$10.90K+203.5%
Q1 FY2017CQ4 2016Nov 30, 2016$3.59K-9.6%
Q4 FY2016CQ3 2016Aug 31, 2016$3.59K-78.9%
Q3 FY2016CQ2 2016May 31, 2016$3.59K-71.5%
Q2 FY2016CQ1 2016Feb 29, 2016$3.59K–
Q1 FY2016CQ4 2015Nov 30, 2015$3.97K–
Q4 FY2015CQ3 2015Aug 31, 2015$17.03K–
Q3 FY2015CQ2 2015May 31, 2015$12.58K–

More Artelo Biosciences figures

See a number that looks wrong?